75 FR 123 pgs. 36694-36695 - Importer of Controlled Substances; Notice of Registration
Type: NOTICEVolume: 75Number: 123Pages: 36694 - 36695
FR document: [FR Doc. 2010-15530 Filed 6-25-10; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated March 16, 2010, and published in the Federal Register on March 24, 2010 (75 FR 14186), Roche Diagnostics Operations Inc., Attn: Regulatory Compliance, 9115 Hague Road, Indianapolis, Indiana 46250, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II:
| Drug | Schedule |
|---|---|
| Lysergic acid diethylamide (7315) | I |
| Tetrahydrocannabinols (7370) | I |
| Alphamethadol (9605) | I |
| Cocaine (9041) | II |
| Ecgonine (9180) | II |
| Methadone (9250) | II |
| Morphine (9300) | II |
The company plans to import the listed controlled substances for the manufacture of diagnostic products for distribution to its customers.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Roche Diagnostics Operations Inc. to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Roche Diagnostics Operations to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed.
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 2010-15530 Filed 6-25-10; 8:45 am]
BILLING CODE 4410-09-P